Navigation Links
California Healthcare Institute Appoints Associate Director, Federal Government Relations and Programs
Date:4/1/2013

La Jolla, CA (PRWEB) April 01, 2013

The California Healthcare Institute (CHI) announced today the appointment of Jennifer Nieto Carey as associate director of federal government relations and programs based in CHI’s Washington, D.C. Office. CHI is a non-profit public policy research and advocacy organization for California’s biomedical R&D industry.

As associate director of federal government relations and programs, Carey assists CHI’s Washington, D.C. office in the development and implementation of outreach/education and legislative advocacy programs, as well as building and maintaining alliances with CHI member companies, partner associations and other affiliate organizations. She joins Todd Gillenwater, senior vice president for public policy, who leads CHI’s D.C. operations.

“With her experience on the Hill and knowledge of our industry, Jenny is a strong addition to the CHI team and will help us raise our industry’s profile in Washington, D.C.,” said CHI President and CEO David L. Gollaher, Ph.D. “This is a critical time to strengthen our advocacy of California’s biomedical industry. The implementation of the Affordable Care Act, pressure on National Institutes of Health science funding, ongoing U.S. Food and Drug Administration regulatory challenges, and increasing coverage and payment challenges – for all these issues the California congressional delegation is more important than ever.”

Before joining CHI, Carey spent six years at FaegreBD Consulting, where she served as assistant vice president of health and biosciences and worked with a range of health and life science sector clients on legislative and policy issues before Congress, the FDA and other state and federal agencies including the Centers for Medicare and Medicaid Services, Centers for Disease Control and Prevention and the NIH. Prior to that, she served in the office of Rep. Anna Eshoo (D-Palo Alto) for four years, rising through the ranks to ultimately serve as the congresswoman’s health policy advisor. Carey holds a bachelor’s degree in political science from the University of California, Davis.

Editorial note: Photo available upon request.

About CHI

CHI represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI’s mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI’s website is http://www.chi.org. Follow us on Twitter @calhealthcare, Facebook, LinkedIn and YouTube.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10585961.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Executives from Johnson & Johnson, GlaxoSmithKline and California State Board of Pharmacy discuss pharmaceutical packaging challenges at Pharmapack North America 2013
2. Cellular Dynamics and Coriell Institute for Medical Research Awarded Multi-Million Dollar Grants from California Institute for Regenerative Medicine to Manufacture and Bank Stem Cell Lines
3. California Healthcare Institute Appoints Vice President-State Government Affairs
4. Genomas Expands Personalized Medicine Business with Clinical Laboratory Licenses in New York, Florida, California
5. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
6. JDRF and California Institute for Regenerative Medicine Increase Funding of ViaCyte
7. The California Healthcare Institute Responds to New Efforts to Repeal the Federal Medical Device Excise Tax
8. California Healthcare Institute Appoints Allergan CEO Chairman of the Board, Elects New Board Members
9. Precision Coating to Showcase Next Generation Coating Deposition Technology at MD&M West Show in Anaheim, California
10. California Biomedical Companies Report Higher Product Approvals, Fewer Delays
11. Bayer CropScience Announces Registration for use of Alion on Grapes in California
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 2017 Research and Markets has announced the ... Global Strategic Business Report" report to their offering. ... This report analyzes the ... Million. Annual estimates and forecasts are provided for the period 2014 ... secondary research. The report profiles 25 companies including ...
(Date:3/24/2017)... , March 24, 2017 Agenus Inc. ... immune checkpoint antibodies and cancer vaccines, today announced participation ... 7 th  Annual William Blair and Maidstone Life Sciences ... Alexandria Center in New York, NY ... March 29 at 9:40 am: Robert B. ...
(Date:3/23/2017)... March 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) ... immune therapies for solid tumor cancers, today announced ... financing it announced last Friday, March 17, 2017. ... institutional investors securities totaling 28,843,692 shares, comprised of ... 10,000,000 shares of Class C Warrants pre-funded at ...
(Date:3/23/2017)... CT (PRWEB) , ... March 23, 2017 , ... ... LLC, was recently selected by the Connecticut Technology Council (CTC) as a 2017 ... at CTC’s thirteenth annual Women of Innovation Awards Dinner. , The dinner recognizes ...
Breaking Biology Technology:
(Date:2/24/2017)...  EyeLock LLC, a leader of iris-based identity ... biometric solution on the latest Qualcomm® Snapdragon™ 835 ... World Congress 2017 (February 27 – March ... 3, Stand 3E10. The Snapdragon ... platform—a combination of hardware, software and biometrics ...
(Date:2/16/2017)... FRANCISCO , Feb. 16, 2017  Genos, ... today announced that it has received Laboratory Accreditation ... CAP Accreditation is presented to laboratories that meet ... who demonstrate scientifically rigorous processes. "Genos ... excellence in laboratory practices. We,re honored to be ...
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
Breaking Biology News(10 mins):